Monday, June 22, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 731 of 1,261
  1. US 9149539

    Crystalline naloxol-PEG conjugate

    Nektar Therapeutics · Granted Oct 6, 2015 · Expires Oct 1, 2035

    granted
  2. US 9149617

    Device, system and methods for the oral delivery of therapeutic compounds

    Rani Therapeutics, LLC · Granted Oct 6, 2015 · Expires Oct 1, 2035

    granted
  3. US 9149501

    Methods of treating depression and other related diseases

    Northwestern University · Granted Oct 6, 2015 · Expires Oct 1, 2035

    granted
  4. US 9149483

    Methods for treatment of diseases

    Galera Labs, LLC · Granted Oct 6, 2015 · Expires Oct 1, 2035

    granted
  5. US 9149479

    Hydroxy-6-heteroarylphenanthridines and their use as PDE4 inhibitors

    TAKEDA GMBH · Granted Oct 6, 2015 · Expires Oct 1, 2035

    granted
  6. US 9149450

    Ischemia/reperfusion protection compositions and methods of using

    Regents of the University of Minnesota · Granted Oct 6, 2015 · Expires Oct 1, 2035

    granted
  7. US 9149468

    Multicomponent crystals made ([2-amino-6-(4-fluoro-benzylamino)-pyridin-3-yl]-carbamic acid ethyl ester and 2-[2-[(2,6-dichlorphenyl)-amino]-phenyl]-acetic acid

    TEVA GmbH · Granted Oct 6, 2015 · Expires Oct 1, 2035

    granted
  8. US 9149445

    Inhibition of glycerol-3-phosphate acyltransferase (GPAT) and associated enzymes for treatment of viral infections

    THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Oct 6, 2015 · Expires Oct 1, 2035

    granted
  9. US 9149437

    Method for treatment of solid pharmaceutical preparation prior to printing and solid pharmaceutical preparation subjected to treatment prior to printing

    Takeda Pharmaceutical Company Limited · Granted Oct 6, 2015 · Expires Oct 1, 2035

    granted
  10. US 9149448

    Methods of treating non-alcoholic steatohepatitis (NASH) using cysteamine products

    The Regents of the University of California · Granted Oct 6, 2015 · Expires Oct 1, 2035

    granted
  11. US 9149446

    Stabilized mutant opsin proteins

    Regents of the University of Minnesota · Granted Oct 6, 2015 · Expires Oct 1, 2035

    granted
  12. US 9150581

    Nicotinic receptor compounds

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Oct 6, 2015 · Expires Oct 1, 2035

    granted
  13. US 9149489

    Inhibitors of glycolysis useful in the treatment of brain tumors

    The Board of Regents of the University of Texas System · Granted Oct 6, 2015 · Expires Oct 1, 2035

    granted
  14. MX 2015008685

    TREATMENT OF PSORIATIC ARTHRITIS USING APREMILAST.

    CELGENE CORP [US] · Granted Oct 5, 2015 · Expires Sep 30, 2035

    granted
  15. TW 201536770

    Urea compounds and their use as enzyme inhibitors

    BIAL PORTELA & CA SA [PT] · Granted Oct 1, 2015 · Expires Sep 26, 2035

    granted
  16. US 9145411

    Substituted amino-pyrimidine derivatives

    Asana BioSciences, LLC · Granted Sep 29, 2015 · Expires Sep 24, 2035

    granted
  17. US 9144551

    Drug formulations having reduced abuse potential

    Supernus Pharmaceuticals, Inc. · Granted Sep 29, 2015 · Expires Sep 24, 2035

    granted
  18. US 9145462

    Glioblastoma multiforme-reactive antibodies and methods of use thereof

    The Regents of the University of California · Granted Sep 29, 2015 · Expires Sep 24, 2035

    granted
  19. US 9144557

    Hematopoietic growth factor mimetic small molecule compounds and their uses

    Ligand Pharmaceuticals Incorporated · Granted Sep 29, 2015 · Expires Sep 24, 2035

    granted
  20. US 9144565

    Method for treating hearing loss

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Sep 29, 2015 · Expires Sep 24, 2035

    granted
  21. US 9144605

    Recombinant rift valley fever virus encoding a dominant-negative inhibitor of DSRNA-dependent protein kinase in the NSS region

    The Board of Regents of the University of Texas System · Granted Sep 29, 2015 · Expires Sep 24, 2035

    granted
  22. US 9145552

    Modified factor X polypeptides and uses thereof

    Catalyst Biosciences, Inc. · Granted Sep 29, 2015 · Expires Sep 24, 2035

    granted
  23. US 9145548

    Foot and mouth disease virus with increased stability and its use as vaccine

    The Pirbright Institute · Granted Sep 29, 2015 · Expires Sep 24, 2035

    granted
  24. US 9144604

    Vaccine for Shigella

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 29, 2015 · Expires Sep 24, 2035

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.